SanaClis, a global full-service CRO with an integrated clinical supply chain, has officially acquired S2 ScienceSolutions, an owner-managed contract research organisation based in Vienna, Austria. The ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Genital herpes is an infection of the genitals, buttocks, or anal area caused by herpes simplex virus (HSV).

However, the rotavirus vaccine (RV) is given by mouth through liquid drops. Diphtheria, Tetanus, Acellular Pertussis (DTaP) The DTaP vaccination is given in five doses. The first dose begins at 2 ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

M.D., Ph.D., a Pfizer-turned-GSK scientist who headed up vaccine R&D and infectious disease research at GSK for three years before leaving the company in late 2024. Before that, Dormitzer spent ...

1 Tony Wood, Chief Scientific Officer at GSK, said: “We welcome this positive recommendation that can help strengthen disease prevention efforts in the US. Pentavalent vaccines can reduce the ...

GSK sued Pfizer in 2023, arguing that the New York-based company's vaccine infringed GSK patents ... Energycategory Oil prices slide 2% to nearly 4-year low as US trade conflict fuels recession ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.

buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for ...

GSK will be awarding another $2 million in COiMMUNITY Initiative grants to support ambitious and actionable efforts to increase US adult immunization rates through vaccine education, outreach and ...